Trinity J. Bivalacqua

Also affiliated with The University of Texas at San Antonio Health Science Center, Hospital of the University of Pennsylvania, Sidney Kimmel Cancer Center, University of Pennsylvania Health System, Sidney Kimmel Comprehensive Cancer Center, The University of Texas at San Antonio, University of Pennsylvania

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 20 papers. Top paper: “Phase 2 Trial of Atezolizumab in Bacillus Calmette-Guérin–unresponsive High-risk Non–muscle-invasive Bladder Cancer: SWOG S1605”.

Phase 2 Trial of Atezolizumab in Bacillus Calmette-Guérin–unresponsive High-risk Non–muscle-invasive Bladder Cancer: SWOG S1605

European Urology(2023)10.1016/j.eururo.2023.08.004

N/A

2.9DataRank · unranked

93 citations

Catherine M. Tangen, Parminder Singh, David J. McConkey, M. Scott Lucia, William T. Lowrance +10 more

Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin–Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial

The Journal of Urology(2024)10.1097/ju.0000000000004020

N/A

1.6DataRank · unranked

77 citations

Stephen A. Boorjian, Mehrdad Alemozaffar, Badrinath R. Konety, Neal D. Shore, Leonard G. Gomella +35 more

Phase II Clinical Chemoprevention Trial of Weekly Erlotinib before Bladder Cancer Surgery

Cancer Prevention Research(2024)10.1158/1940-6207.capr-24-0194

N/A

0.220DataRank · unranked

2 citations

Howard H. Bailey, Taja Ložar, Natalie Schmitz, Heather Green, Cameron O. Scarlett +15 more

MP55-18 SARCOMATOID UROTHELIAL CARCINOMA: CLINICO-PATHOLOGICAL ANALYSIS OF 93 CASES WITH EMPHASIS ON PT1 OUTCOMES IN PATIENTS WHO UNDERWENT EARLY CYSTECTOMY AND/OR NEOADJUVANT CHEMOTHERAPY

The Journal of Urology(2020)10.1097/ju.0000000000000924.018

N/A

0DataRank · unranked

0 citations

Kara A. Lombardo, Woonyoung Choi, Trinity J. Bivalacqua, Max Kates, Noah M. Hahn +3 more

Predictive models of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer using nuclear morphology and tissue architecture

Cell Reports Medicine(2021)10.1016/j.xcrm.2021.100382

N/A

0DataRank · unranked

46 citations

Trinity J. Bivalacqua, Max Kates, Roland Seiler, Peter C. Black, Aleksander S. Popel +2 more

BCG invokes superior STING‐mediated innate immune response over radiotherapy in a carcinogen murine model of urothelial cancer

The Journal of Pathology(2021)10.1002/path.5830

N/A

0DataRank · unranked

20 citations

Aleksandar Obradović, Alok Kumar Singh, James L. Liu, Gregory Joice, Max Kates +11 more

Recombinant BCGs for tuberculosis and bladder cancer

Vaccine(2021)10.1016/j.vaccine.2021.09.040

N/A

0DataRank · unranked

20 citations

Geetha Srikrishna, Trinity J. Bivalacqua, William R. Bishai, Alok Kumar Singh

Rapamycin Suppresses Penile NADPH Oxidase Activity to Preserve Erectile Function in Mice Fed a Western Diet

Biomedicines(2021)10.3390/biomedicines10010068

N/A

0DataRank · unranked

8 citations

Clifford J. Pierre, Trinity J. Bivalacqua, Arthur L. Burnett, Justin D. La Favor

Increased Level of Tumor Necrosis Factor-Alpha (TNF-α) Leads to Downregulation of Nitrergic Neurons Following Bilateral Cavernous Nerve Injury and Modulates Penile Smooth Tone

The Journal of Sexual Medicine(2021)10.1016/j.jsxm.2021.05.001

N/A

0DataRank · unranked

9 citations

Nikolai A. Sopko, Jeffrey Campbell, Xiaopu Liu, Allison Reinhardt, Emmanuel Weyne +5 more

Phase II trial of atezolizumab in BCG-unresponsive non-muscle invasive bladder cancer: SWOG S1605 (NCT #02844816).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.4541

N/A

0DataRank · unranked

27 citations

Catherine M. Tangen, Parminder Singh, David J. McConkey, Scott Lucia, William T. Lowrance +10 more

RETRACTED ARTICLE: Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancer

Nature Communications(2022)10.1038/s41467-022-28509-z

N/A

0DataRank · unranked

98 citations

Monali Praharaj, Kara A. Lombardo, Takahiro Yoshida, Andrés Matoso, Alex S. Baras +11 more

Dynamic single-cell RNA sequencing reveals BCG vaccination curtails SARS-CoV-2 induced disease severity and lung inflammation

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.15.484018

N/A

0DataRank · unranked

11 citations

Rulin Wang, Kara A. Lombardo, Monali Praharaj, C. Korin Bullen, Peter Um +13 more

Systematic Elucidation and Pharmacological Targeting of Tumor-Infiltrating Regulatory T Cell Master Regulators

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.02.22.481404

N/A

0DataRank · unranked

6 citations

Casey R. Ager, Mikko Turunen, Thomas R. Nirschl, Mohsen Khosravi‐Maharlooei, Christopher M. Jackson +10 more

Systematic elucidation and pharmacological targeting of tumor-infiltrating regulatory T cell master regulators

Cancer Cell(2023)10.1016/j.ccell.2023.04.003

N/A

0DataRank · unranked

58 citations

Casey R. Ager, Mikko Turunen, Thomas R. Nirschl, Mohsen Khosravi‐Maharlooei, Alina C. Iuga +16 more

A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER Study

European Urology(2023)10.1016/j.eururo.2023.01.017

N/A

0DataRank · unranked

56 citations

Michael A. O’Donnell, Jason A. Efstathiou, Marianna Zahurak, Gary L. Rosner, Jeff Smith +36 more

Improved bladder cancer antitumor efficacy with a recombinant BCG that releases a STING agonist

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.15.571740

N/A

0DataRank · unranked

6 citations

Monali Praharaj, Kara A. Lombardo, Takahiro Yoshida, Andrés Matoso, Alex S. Baras +10 more

Preclinical evaluation of a hypotonic docetaxel nanosuspension formulation for intravesical treatment of non-muscle-invasive bladder cancer

Drug Delivery and Translational Research(2020)10.1007/s13346-020-00870-w

N/A

0DataRank · unranked

11 citations

Max Kates, Takahiro Yoshida, Taarika Babu, Umara Afzal, Pranjali Kanvinde +8 more

Urine Tumor DNA to Stratify the Risk of Recurrence in Patients Treated with Atezolizumab for Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer

European Urology(2025)10.1016/j.eururo.2025.03.023

N/A

0DataRank · unranked

15 citations

Parminder Singh, David J. McConkey, M. Scott Lucia, Vadim S. Koshkin, Kelly Stratton +16 more

Phase II trial of atezolizumab in BCG-unresponsive non-muscle invasive bladder cancer: SWOG S1605 (NCT #02844816).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.5022

N/A

0DataRank · unranked

55 citations

Catherine M. Tangen, Parminder Singh, David J. McConkey, Scott Lucia, William T. Lowrance +11 more

WITHDRAWN: Recombinant BCG overexpressing a STING agonist elicits trained immunity and improved antitumor efficacy in non-muscle invasive bladder cancer

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.04.25.061531

N/A

0DataRank · unranked

6 citations

Monali Praharaj, Kara A. Lombardo, Takahiro Yoshida, Andrés Matoso, Alex S. Baras +9 more